| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 09/29/2026 | ±2.3% | -0.3% | over-priced |
| 05/29/2026 | ±4.2% | -1.5% | over-priced |
| 03/03/2026 | ±3.1% | +0.4% | over-priced |
| 11/24/2025 | ±2.3% | -4.5% | under-priced |
| 09/26/2025 | ±1.6% | -0.0% | over-priced |
| 06/03/2025 | ±2.5% | +0.4% | over-priced |
| 02/26/2025 | ±2.9% | -0.9% | over-priced |
| 11/26/2024 | ±3.7% | +0.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2026 | — | $1.2B | $327M |
| Q3 FY2026 | $0.43 | $1.2B | $402M |
| Q2 FY2026 | $0.36 | $1.1B | $351M |
| Q1 FY2026 | $0.41 | $1.2B | $404M |
CPRT (CPRT) reports in 64 days, with the next report estimated for 12/30/2026. Across the last 8 reports, options priced an average ±2.8% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced CPRT's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 2.4%. QuantLogix's live 5-factor engine currently reads CPRT as a buy at 61/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →